"Credit goes to country`s scientists and also government system that delivered vaccine to the last mile of delivery. We proved to the world that Indian industry can do it," said Chairman and Managing Director of Bharat Biotech Dr Krishna Ella.
As India on Thursday achieved the milestone of administering 100 crore COVID-19 vaccine doses so far, Chairman and Managing Director of Bharat Biotech Dr Krishna Ella lauded the government's system for this achievement.
Bharat Biotech signs agreements with US, Brazil to export, outsource COVAXIN production The first interim reading of efficacy data from Phase III will be out in March, according to Bharat Biotech MD and CEO Dr Krishna Ella. tech2 News Staff February 04, 2021 11:50:50 IST An illustration of COVAXIN, the vaccine candidate for COVID-19 developed by Bharath Biotech. Image: Bharath Biotech
India s first indigenous COVID-19 vaccine Covaxin, co-developed by Bharat Biotech along with the Indian Council of Medical Research (ICMR)–National Institute of Virology (NIV), is going to be shipped globally, according to the Indian vaccinemaker. While the vaccine was given
emergency use approval by the Drugs Controller General of India in early January, it is still currently in Phase III clinical trials with around 26,000 volunteers around the country and Phase I a
Bharat Biotech to supply Covaxin to Brazil, inks deal with Precisa Medicamentos
The Government of Brazil will procure Covaxin directly from Bharat Biotech while supply to the private market will be subjected to authorisation from Brazilian regulatory authority ANVISA.
advertisement
UPDATED: January 12, 2021 18:27 IST
64 envoys from various countries visiting Bharat Biotech s facility in Hyderabad on December 9 (Photo Credits: PTI)
Bharat Biotech Tuesday signed an agreement with Precisa Medicamentos to supply its Covid-19 vaccine Covaxin to Brazil. Earlier, a team from Precisa Medicamentos visited the Bharat Biotech facility ahead of discussing potential export possibilities of India s first indigenous vaccine for cororonavirus.
According to a press release by the Hyderabad-based pharma company, the team met Bharat Biotech chief Dr Krishna Ella on January 7 and January 8 at its facility in Hyderabad s Genome Valley. Ambassador of Brazil to India, André Aranha Corrêa do Lago al
The indicators are that Covaxin has a very high efficacy, ICMR said (Representational)
New Delhi:
The Indian Council for Medical Research (ICMR) confirmed today that it had not received Phase 3 efficacy or effectiveness data of one of the Covid vaccines that the government s drug regulator has cleared for emergency use.
Asked specifically to comment on the efficacy of Covaxin, the drug manufactured by Bharat Biotech, Dr Balram Bhargava, the Director General of the Indian Council of Medical Research, told NDTV, The indicators are that it has a very high efficacy, but declined to provide any specific detail. An efficacy report, he said, would be (available) within weeks.